Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026)

Biomarin Pharmaceutical (BMRN) has 13 years of Exchange Rate Effect data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Exchange Rate Effect rose 199.58% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305000.0 (down 79.49% YoY) and the FY2025 annual result came in at -$2.5 million, down 152.19% from the prior year.
• Exchange Rate Effect rose to $1.4 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $3.3 million in Q2 2024 to a low of -$3.6 million in Q4 2023.
• A 5-year average of $297588.2 and a median of $739000.0 in 2025 frame the typical range for Exchange Rate Effect.
• The widest YoY moves for Exchange Rate Effect: up 814.81% in 2023, down 5236.62% in 2023.
• Tracing BMRN's Exchange Rate Effect over 5 years: stood at $71000.0 in 2022, then slumped by 5236.62% to -$3.6 million in 2023, then soared by 168.66% to $2.5 million in 2024, then slumped by 51.32% to $1.2 million in 2025, then advanced by 15.67% to $1.4 million in 2026.
• The last three Exchange Rate Effect figures came in at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $739000.0 (Q3 2025), per Business Quant data.